Evaluation of the Use of Drug Therapy-Related Quality of Life Measure in Pharmaceutical Care for Outpatients
Article Sidebar
Main Article Content
Abstract
Objective: To compare the effect of pharmaceutical care in terms of drug-related quality of life between patients with the use of the Patient-Reported Outcome Measure of Pharmaceutical Therapy (PROMPT) in the provision of pharmaceutical care and those without the use of the PROMPT. Methods: The study was a single-blind, randomized, controlled intervention study in 315 outpatients at Samutprakan hospital during August 2018 to February 2019. The study randomly allocated patients into standard group (with no use of the PROMPT in the provision of pharmaceutical care) and the intervention group (with the use of the PROMPT). The researchers collected data with the PROMPT twice i.e., before and after intervention during nest patient visit. Results: After the provision of pharmaceutical care, Intervention group had a significantly higher score on overall quality of life, compared to standard group with mean of 82.1±16.7 and 78.6±16.2, respectively. Conclusions: The use of PROMPT in pharmaceutical care increased drug-related quality of life in overall quality of life domain.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Cheng Y, Raisch DW, Borrego ME, Gupchup GV. Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: A literature review. Res Social Adm Pharm. 2013; 9: 311-29.
Kozma CM, Reeder CE, Schulz RM,. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15:1121-32.
Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: A new era in clinical research. Perspect Clin Res. 2011; 2: 137-44.
US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims [online]. 2009 [cited Jan 20, 2018]. Available from: www.fda.gov/downloads/drugs/guidances/ucm 193282.pdf.
Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
Jones JB, Synder CF WA. Issues in the design of internet-based systems for collecting patient-reported outcomes. Qual Life Res. 2007;16:1407-17.
Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998; 2: 1-74.
US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
Guyatt GH, Feeny DH, Patrick DL. MEasuring health-related quality of life. Ann Intern Med. 1993; 118: 622-9.
Sakthong P. Health-related quality of life. Bangkok: Chulalongkorn University Press; 2011.
Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60: 833-43.
Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: A structured review. J Eval Clin Pract. 2006; 12: 559-68.
Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psycho-Oncology. 2000;9:203-13.
Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: A randomized controlled trial. JAMA. 2002; 288: 3027-34.
Weaver A, Young AM, Rowntree J, Townsend N, Pearson S, Smith J, et al. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007;18:1887-92.
Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: A randomized trial. J Clin Oncol. 2011;29:1029-35.
Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 2013;13:211-.
Sakthong P, Suksanga P, Sakulbumrungsil R, Winit-Watjana. Development of Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL): A novel instrument for medication management. Res Social Adm Pharm. 2015;11:315-38.
Sakthong P, Sangthonganotai T. A randomized controlled trial of the impact of pharmacist-led patient-centered pharmaceutical care on patients' medicine therapy-related quality of life. Res Social Adm Pharm. 2018;14:332-9.
Sakthong P, Sonsa-ardjit N, Sukarnjanaset P, Munpan W, Sangthonganotai T. Development and psychometrics of a short-form pharmaceutical care-specific measure for quality of life. Int J Clin Pharm 2018; 40 :642-9.
Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41: 1149-60.
Santana M-J, Feeny D, Johnson JA, McAlister FA, Kim D, Weinkauf J, et al. Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Qual Life Res. 2010;19: 371-9.
Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol. 2004;22:714-24.
